article thumbnail

Digitalising drug discovery

pharmaphorum

As data and digital technology become vital to every aspect of life sciences, the industry is increasingly looking beyond biologists, chemists, and doctors to drive its drug development – and finding that technology has a chief role to play in the future of medicine. on Big data: astronomical or genomical? ,

article thumbnail

Medical Informatics: a bridge between two worlds

pharmaphorum

Her research area is the secondary use of observational data of patients with rare and unclear diseases; with attention to the research data infrastructure and terminologies. In 2021, she co-founded OHDSI Germany, which is as a national node of the Observational Health Data Sciences and Informatics (OHDSI) Europe. .

Genome 78
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Building the hospital of the future

pharmaphorum

Every patient, every doctor or nurse, every hospital worker is a human being influenced by their experiences outside of healthcare. centric care model to a more virtual distributed care model that heavily leverages the latest technologies around artificial intelligence, deep learning, data analytics, genomics, home?based

article thumbnail

Medical Informatics and Rare Disease: a bridge between two worlds

pharmaphorum

And this is where modern technologies and data-driven medical informatics can really bridge the gaps in rare disease research,” said Dr Joanne Hackett, head of Genomic and Precision Medicine at IQVIA, during a recent pharmaphorum webinar.

Genome 104
article thumbnail

Healthcare in 2021: Top Disruptions Bound To Impact The Way Healthcare Is Delivered

Delveinsight

The wearables collect and analyze users’ real-time medical data, which is more comfortable for physicians and doctors to examine. The collected data and the genomic studies can play a crucial role in monitoring the symptoms and predicting potential diseases. . Cybersecurity in Healthcare.

Doctors 52
article thumbnail

Kiromic Announces the Filing of Key European Patents for Its Chimeric PD-1 (chPD1) Target

The Pharma Data

Longwood has a robust research department with 7 post doctorates conducting research in molecular biology, microbiology, genomics, cancer biology, and immunology and publishing over 75 publications in different scientific journals in the past 5 years. Barber also serves on Kiromic’s Scientific Advisory Board. About Longwood University.

In-Vivo 40
article thumbnail

The rise of real-world evidence: unlocking the potential in EHRs

pharmaphorum

By extracting and reading unstructured information buried within the free text of clinical notes, Savana’s technology and clinical research methodology is enabling clinicians and health researchers around the world to analyse vast amounts of previously inaccessible clinical data. “We Fragmentation of information is our enemy.

Doctors 113